Navigation Links
Bottled Water Contains Coliform Bacteria and Diatoms

The New York State Department of Health has confirmed coliform bacteria and diatoms in some samples of bottled water produced by North Country Spring Water//, Ltd. For this reason North Country Spring Water, Ltd. of Port Kent is voluntarily recalling all of its bottled water products. Coliform bacteria are naturally present in the environment.

But presence of coliform bacteria in bottled water is a violation of the New York State Sanitary Code. Coliform bacteria may indicate the presence of other potential contamination. The presence of diatoms is an indication that untreated or partially treated surface water is contaminating the source water used in the bottling process.

The bottled water was distributed wholesale in New York, Vermont and New Jersey from where they were sold to consumers through retail stores and direct delivery. So far no illnesses have been confirmed. Individuals who are weak, old, immunosuppressed and suffer from any disease should consult with their health care provider. Subsequent investigation has already stated and they suspect that a temporary breakdown in the company's filtration system could be a main reason behind the scenario.


'"/>




Page: 1

Related medicine news :

1. Bottled Contamination And a Brewing Battle
2. Ark Land Brand Bottled Water Faces a Bottleneck
3. Water - The silent killer!!!
4. Water regulation in humans
5. Salt-Water Pools Good for the Health
6. Water Exercise Found to be Effective for Patients with Osteoarthritis
7. Water borne diseases, need caution
8. Water pills for diabetic with high blood pressure
9. Drinking Calcium Water Can Reduce Osteoporosis.
10. 233 Dead in Mumbai and Thane due to Water Borne Diseases
11. Water Borne Diseases causing More Havoc in Mumbai
Post Your Comments:
(Date:7/3/2009)...earchers express hope that finding will lead to tr... News) -- U.S. researchers say they,ve found a ma...of relapsed lung cancer. , When caught early, l...e not detected until the disease is well advanced....remission, the disease often springs back more vir...
(Date:7/3/2009)... A new urine drug test kit c...g solution for individuals that want a fast and ac...pany Confirm BioSciences, the cup has a sleek, inn...chnology. It’s also very competitively price...e currently being sold on the market , ...
(Date:7/3/2009)... Upstate HomeCare, a home me...specialty medication, respiratory and DME services...Y have opened. One specializes in home infusion th...ne for Upstate HomeCare. , ...meCare , a home medical services provider speciali...
(Date:7/2/2009)... FORT MYERS, Fla., July 2 /PRNewswire-USNewswire/ ...er-the-counter and prescription medicines to help ...to acetaminophen by a brand name, Tylenol and pres..., An advisory committee for the FDA met on June 30...e use of acetaminophen. The committee voted 20-17...
Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2
...stone that kills two vices. United States FDA-appr...osing to be handed out to alcoholics as well . T...hantix, which has been used quite successfully by ...reveal the same effects in alcoholics too, of the ...
...onwide folic acid fortification of enriched grains...the United States and Canada with neural tube defe...ncurrent with the institution of fortification, ho...olorectal cancer were diagnosed in men and women i...
...x Brain, targeting brain cancer victims has found ...Bothell-based biotech company Northwest Biotherape...hat works by empowering the immune system to fight...pany works to gain access to American and European...
--Dr. Albert A. Bartlett, Emeritus Professor of Physics, University of Colorado From time immemorial, the human male has exuded raw power and supremacy over the female. The animal kingdom, too, is no
Other Medicine News:Health News:Two In One Drug For Smokers And Drinkers 2Health News:Folicacid Fortification Very Beneficial 2Health News:Folicacid Fortification Very Beneficial 3Health News:MEN as Partners to MEND Maternal Health A World Population Day Initiative 2Health News:MEN as Partners to MEND Maternal Health A World Population Day Initiative 3
(Date:6/29/2009)...une 29 Vantia Therapeutics, an,em...all molecule drugs,targeting large, underserved m... Phase IIa clinical trial of its lead development ...that oral VA106483 was successful in producing a,...patients, as determined by,increased osmolality a...
(Date:6/26/2009)...nd OSAKA, Japan, June 27, 2009 Tak...y announced that Takeda Global Research & Deve... (U.S.) subsidiary received on June 26 (U.S. time)... Drug Administration (FDA) regarding the Company,s...ctive dipeptidyl peptidase IV (DPP-4) inhibitor un...
(Date:6/26/2009)... Approval of New Anti-TNF Therapy in Three Rheumat..., , HORSHAM, Pa. and KENILWORTH, N.J., June 26 ...nc. and Schering-Plough Corporation (NYSE: SGP )...Products for Human Use (CHMP) of the European Medi...ommending the approval of SIMPONI(TM) (golimumab) ...
(Date:6/25/2009)...t Covering ARIKACE for Once-Daily Treatment of Pse... N.J., June 25 Cystic Fibrosis Fou... of the Cystic Fibrosis Foundation, has provided a...inued development of ARIKACE(TM) (liposomal amikac...at Pseudomonas lung infections in cystic fibrosi...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4ACP pledges support for Medicare improvements for Patients and Providers Act of 2008 21350 1ACP pledges support for Medicare improvements for Patients and Providers Act of 2008 21350 2Livermore researchers use carbon nanotubes for molecular transport 3587 1Livermore researchers use carbon nanotubes for molecular transport 3587 2Antibiotics can prevent wound complications of childbirth Stanford Packard study finds 21348 1Antibiotics can prevent wound complications of childbirth Stanford Packard study finds 21348 2Mylan Announces Final FDA Approval for Zaleplon Capsules 21346 1
...cacy trends from ongoing phase I/II trial,of oncol...n in,press conference , MARTINSRIED, Germany, June...furt, Prime Standard: MDG) announces that a case,r...s cancer killing,virus will be presented in a pres...cal Oncology. Out of more than 300 posters accepte...
...cokinetics and Dose Proportionality of,Company,s O...tics,Journal -, LAVAL, QC, June 29, 2007 /PRNewswi...t it will present a poster discussing the dose,tit...t the 3rd,International Forum on Pain Medicine to ...a. , The poster compares two different titration s...
Other Medicine Technology:European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3
Bipolar forceps 6.7 cm 2-11/16" or 3/32" (bent) coated.
Straight, blunt tips.
Angulated, blunt tips.
Disposable 1 1/4" Tungsten Micro Needle, Ins., Straight
Medicine Products: